Date: 23 June 2021
The webinar assessed the current state of play and prospects for an intellectual property (IP) waiver in response to the Covid-19 pandemic. The panel assessed the proposal of India and South Africa for a TRIPS waiver, the announcement that the United States is prepared to support the waiving of IP for Covid-19 vaccines, and the counter proposal of the EU.
The event was jointly hosted by the Queen Mary Intellectual Property Research Institute (QMIPRI), Queen Mary University of London, and the Intellectual and Industrial Property Rights Research and Application Center (FISAUM), Ankara University.